August, 2015:
- ASCO Updates Metastatic Lung Cancer Therapy Guideline to Include Targeted Agents, Early Palliative Care
- Gemcitabine Plus Docetaxel May Be Better Tolerated for Localized Soft Tissue Sarcoma
- In Cutaneous Melanoma, Early Sentinel-Node Biopsy Associated with Poorer Survival
- Single Organ Metastases in NSCLC Linked with Better Outcomes
- In Breast Cancer, Physician Peers Influence Treatment Adoption
- Immunotherapy Combinations for Renal Cell Carcinoma Offer Promise, Challenges
- Association of 21-Gene Recurrence Score Assay, Chemo in Early-stage Breast Cancer
- In Heavily Pretreated Refractory Myeloma, Daratumumab May Be Safe, Effective
- In Locoregionally Advanced Oral Cavity Cancer, Preop Induction Chemo May Not Improve Outcomes
- Patients With Solid Tumors Face Risk for Critical Illness
- Dasatinib Plus Chemo Achieves Long-Term Remission in Ph+ Acute Leukemia
- Patupilone Shows Activity in Recurrent NSCLC Brain Metastases
- How Many People Does it Take to Increase Colorectal Cancer Screening to 80%?
- The association between obesity and gastrointestinal cancer
- Blood Test May Predict Relapse in Early-Stage Breast Cancer
- ERCC1 Genotype Can Identify Good Prognosis in Nasopharyngeal Cancer
- Most Women Experience Anxiety With False-Positive Mammograms
- Higher Travel Burden, Non-private Insurance Linked With Less Likelihood for Adjuvant Chemo
- Hypertension Not a Predictor for Pazopanib Efficacy
- Ibandronate May Be Alternative to Radiotherapy for Metastatic Prostate Bone Pain
- No Association Between Common Genetic Mutations, Prostate Cancer Survival
- In Breast Cancer Survivors, Acupuncture Better Than Pills for Hot Flashes
- Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity
- Electronic Intervention May Reduce Time to Diagnostic Evaluation
- In Follicular Lymphoma, Adding Rituximab to Lenalidomide May Improve Activity
- Adding Trebananib to Sunitinib May Improve Renal Cell Carcinoma Outcomes
- Regorafenib Not Cost-effective for Third-line Treatment of Colorectal Cancer
- Music May Reduce Anxiety Score in Breast Cancer Surgery Patients
- Circulating Tumor Cell Assays May Play Role in Bladder Cancer Management
- Low-Dose Aspirin, NSAIDs May Lower Colorectal Cancer Risk
- FDA Grants Breakthrough Therapy Designation to Cabozantinib for Renal Cell Carcinoma
- Dasatinib-induced Pulmonary Hypertension in Patients With Leukemia
- Arsenic Trioxide for Acute Promyelocytic Leukemia Reduces Risk for Relapse
- In Fit Patients With NSCLC, Erlotinib Not Recommended
- For Certain Nasal Type Lymphoma, ESHAP Regimen Plus Radiotherapy Efficacious
- New Hormonal Agents for Prostate Cancer May Increase Risk of Cardiotoxicity
- Veterans May Face Poorer Oral, Throat Cancer Outcomes
- Non-Invasive Laser Technique May Accurately Detect Melanoma
- Fewer Moles May Suggest More Aggressive Melanoma
- Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable
- Age, Black Ethnicity Identified as Risk Factors for Death After DCIS Diagnosis
- Neutrophil Count May Be Associated with Survival in Localized Prostate Cancer
- Adding Elotuzumab to Relapsed, Refractory Myeloma Treatment Improves Survival
- Combination PANVAC, Docetaxel May Provide Benefit in Breast Cancer
- PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms
- Surgery May Provide Most Benefit for Interdigitating Dendritic Cell Sarcoma
- Gender May Influence VAC Treatment Outcomes in Ewing Sarcoma
- Tinzaparin May Not Lower Risk of Recurrent VTE in Active Cancer
- Obesity May Promote Breast Cancer by Changing Tissue Structure
- Risk Stratification Could Make Colorectal Cancer Screening More Efficient
- In Relapsed Indolent Lymphoma, Obinutuzumab May Be More Active than Rituximab
- Second-line Everolimus Safe, Effective for VEGF-refractory Renal Cell Carcinoma
- Mutations that Could Better Stratify Patients With Myeloma Identified
- In Melanoma, Immune-related Adverse Events Common With Ipilimumab Treatment
- Light, Moderate Drinking Raises Breast Cancer Risk in Women
- Across Racial Groups, Endometrial Cancer Incidence on the Rise
- Higher Coffee Intake May Be Linked With Reduced Colon Cancer Recurrence, Death
- In Newly Diagnosed Myeloma, Continuous Therapy Improves Survival
- Radio Frequency Ablation May Produce More Favorable Outcomes in Papillary Neoplasms
- Risk Assessment Identifies Women at High Risk for Breast Cancer
- Obese Patients With Lynch Syndrome at Higher Risk for Colorectal Cancer
- Adcetris Approved for Classical Hodgkin Lymphoma at High Risk for Relapse, Progression
- Early Initiation of Menstruation May Influence Breast Cancer Risk in Black Women
- Early Docetaxel With ADT Improves Survival in Metastatic Prostate Cancer
- Importance of Reporting Gleason Score at the Positive Surgical Margin Site Assessed
- Transplant Recipients May Be More Likely to Develop Aggressive Melanoma
- No Association Between Post-traumatic Stress, Cancer Risk
- Low-risk Patients With Chronic Leukemia Have Durable Remission After FCR
- Childhood Cancer Survivors Face Higher Risk for Bowel Obstruction
- FIT-Based Screening Impacts Proximal, Distal Colorectal Cancer Rates
- Risk for Death After Lung Cancer Resection Linked With Hospital Mortality Rate
- Patients With Myeloma Refractory to Induction with Novel Agents Have Poor Outcomes
- Molecular Profiles Can be Used for Early Detection for Aggressive Prostate Cancer
- Phase 2 Study for Venetoclax Meets Primary Endpoint in Chronic Leukemia
- RAD51 Mutations Linked With Moderate Ovarian Cancer Risk
- Multigene Testing Identifies More Mutations in Breast, Ovarian Cancer
- In Childhood Cancer Survivors, High Risk for Subsequent Neoplasms
- Sun Exposure in the Military Raises Skin Cancer Risk in Veterans
- For First-line Treatment for Colorectal Cancer, Nintedanib Plus mFOLFOX6 Appears Efficacious
- Better Preoperative Coordination of Care Needed for Patients With Lung Cancer
- Sunitinib Shows Activity in Mucosal, Acral Melanoma
- FDA Approves Labeling Update to Include New Sprycel Data
- Hepatic Resection Provides Long-term Cure for About 10% of Patients With ICC
- Routine Clinical Genetic Testing Should Include RAD51C, RAD51D, Study Suggests
- Smoking is Risk Factor for Certain Renal Cell Carcinoma Subtypes
- Rolapitant Well-tolerated for Chemotherapy-Induced Nausea, Vomiting
- Blood, Marrow Transplantation With Cyclophosphamide May Improve Survival
- Brentuximab Vedotin Active, Well-tolerated in Cutaneous T-Cell Lymphoma
- Use of Radiotherapy After Chemo for Lymphoma Declining
- Non-Hodgkin Lymphoma of the Stomach in a Patient Treated With Natalizumab
- About 30 Percent wth Epithelial Ovarian Cancer Survive Long-term
- Medicare to Now Cover Expensive New Leukemia Medication
- IMWG Revises International Staging System for Multiple Myeloma
- Racial Disparities Exist in Post-Surgical Quality of Life in Lung Cancer
- Prostate Cancer May Impact Relationship Satisfaction Among Couples
- Integrating Mutational Status With Immunochemotherapy Beneficial in Lymphoma
- Religion, Spirituality May be Associated With Physical Outcomes in Cancer
- Limited Resection Not Equivalent to Lobectomy in NSCLC
- Increase in Chest Scans May Lead to More Incidental Pulmonary Findings
- Hypofractionated Whole-Breast Irradiation May Lead to Lower Rate of Toxic Effects
- In Melanoma, Adjuvant Lymph Node Field Radiotherapy Does Not Impact Survival
- Hypofractionated Radiotherapy May Improve Quality of Life in Breast Cancer
- Cavity Shaving Shows Benefit During Partial Mastectomy for Breast Cancer
- Sharing Decisions in Cancer Care Important but Difficult to Implement
- Patients With PIK3CA Mutations Less Likely to Benefit From Dual Anti-HER2 Inhibition
- Stratifying for Distant Brain Failure, Whole-brain Radiotherapy Beneficial
- Combination Therapy May Benefit Patients With BRAF V600E/K Mutation-Positive Melanoma
- No Significant Differences in Symptoms, Physical Decline in Hematologic Malignancies, Solid Tumors
- In Resectable Esophageal, EGJ Cancer, Chemoradiotherapy Improves Survival
- Botulinum Toxin A May Improve Painful Cutaneous Leiomyomas
- Mutations Could Guide Treatment for Bladder Cancer
- Consuming Spicy Foods May Lower Mortality Risk
- Combining Aromatase Inhibitors, Bisphosphonates May Benefit Women With Breast Cancer
- After Treatment, Patients With Germ Cell Cancer Face High Toxicity, Death Risk
- In Stage 1A Hodgkin Lymphoma, Involved-field Radiotherapy Should Be Standard of Care
- Oral Contraceptives May Protect Against Endometrial Cancer
- Patients with Testicular Nonseminoma More Likely to Die of Cardiovascular Disease With Chemo
- How to Approach Patients With Metastatic Breast Cancer for Research Biopsies
- Cardiotoxicity Induced by Trastuzumab Therapy in HER2-positive Breast Cancer
- Identifying Common Treatment Recommendations in Clear Cell Renal Cell Carcinoma
- Cervical Cancer Survival Influenced by Presence of Diabetes Mellitus
- Concerns Raised Regarding Delays in Mandatory Drug Death Reporting
- IP/IV Chemotherapy Associated With Improved Survival in Ovarian Cancer
- For Older Patients With Lung Cancer, Limited Resection Not Equivalent to Lobectomy
- Quality of Life, Cost-effectiveness of Radioiodine Ablation in Thyroid Cancer Assessed
- Immune Therapy May Raise Melanoma Risk in Certain Lymphoma Survivors
- Postoperative Weight Gain May Contribute to Development of Lymphedema
- Robotic Surgery Feasible for Inferior Vena Cava Thrombectomy
- Antibiotic Timing Not a Significant Factor in Outcomes of Febrile Neutropenia
- No Definite Link Between Yoga, Quality of Life in Patients With Colorectal Cancer
- Understanding Aspects of Patients' Experience of Recurrence Important
- ASCO Statement on Increasing the Number of Older Patients in Clinical Trials
- Internal Mammary, Medial Supraclavicular Irradiation in Breast Cancer Evaluated
- Adjuvant Bisphosphonates for Breast Cancer May Reduce Recurrence in Bone, Improve Survival
- Ponatinib May Be Considered for First-line Treatment for Chronic Phase CML
- Worse Gynecologic Cancer Outcomes in Women Enrolled in Both Medicare, Medicaid
- Negative Patient Care Perceptions Linked to Increased Number of Pre-diagnostic Consultations
- Greater Anxiety Linked With Unmet Information Needs in Precancerous Oral Lesions
- Timing, Accuracy for Pre-Op Lung Cancer Evaluation Can Be Improved
- Factors for MAPK Inhibitor Treatment Outcomes in Melanoma Identified
- Clinicians Still Have Concerns Regarding Melanoma Treatment Options
- Adolescent Exercise Linked to Reduced Risk of Cancer, Cardiovascular Disease
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Prostate Cancer | Regimens | Drugs |
Rare Cancers | Regimens | |
Renal Cell Carcinoma | Regimens | Drugs |
Skin Cancer | Regimens | Drugs |
Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Lenalidomide: Feasible for Patients With Relapsed, Refractory MCL
- Bloodroot and Cancer
- Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer
- ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer
- Acetaminophen May Decrease Opioid Use After Head and Neck Cancer Surgery